Skip to content

The effect of Nigella sativa cream on pain and wound healing of episiotomy in Primiparous women

The effect of Nigella sativa cream on pain and wound healing of episiotomy in Primiparous women

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20170425033642N1
Enrollment
135
Registered
2018-01-07
Start date
2017-04-17
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Wound healing of episiotomy , pain of episiotomy. Disruption of perineal obstetric wound

Interventions

Intervention 1: In the intervention group, nigella sativa cream (0.5 %) percent of the combined value is Cold Cream with nigella sativa has been used. Units of study nigella sativa cream the size of a
Treatment - Drugs
Placebo
In the intervention group, nigella sativa cream (0.5 %) percent of the combined value is Cold Cream with nigella sativa has been used. Units of study nigella sativa cream the size of a finger is place
Intervention group: Units of study placebo cream the size of a finger is placed(containing simple base cream) on the sutures so that the wound is completely covered and do the daily double (each 12h)
The control group will be cured at the hospital during the 10 days.

Sponsors

Mashhad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 35 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: nulliparous women aged 18-35 years old; living in the city of Birjand, Iran; at least having the ability to read and write; living with his wife's; body mass index ranging from 19/8-30; non-smoking and no drug dependence; no history of disease impaired wound healing; not using drugs effecting on wound healing; single fetal cephalic; lack of symptomatic infections of the vagina and vulva (the infectious discharge, itching, burning); low blood, anal lesions; vulva and perineum on admission; and rupture of the fetal sac up to 12 hours before the start of pains; lack of stricture restriction pelvic; embryos is vital; the lack of apparent anomalies in the newborn. No rectocel, cystocele severe (grade 2 or higher), wall or mass in the vaginal; no history of obstetric complications; no history of vaginal reconstructive surgery on the Vagina and urethra.

Exclusion criteria

Exclusion criteria: Exclusion criteria: there interfere with the progress of labor; prolonged second stage of labor longer than 2 hours; delivery devices (vacuum, forceps); delivered via cesarean section; extend the length of the incision or there tear except episiotomy tear; infant hospitalization in the NICU; abnormal vaginal bleeding; shoulder dystocia (leading to the maneuvers other than Robert Mack); manual removal of placenta; hematoma; having intercourse to the end of the study (10days postpartum); curettage procedure the first 24 hours after birth; the third stage of labor longer than 30 minutes; the occurrence of an adverse event at 10 days postpartum; no need for episiotomy; not use the cream on a regular; puerperal fever; complications resulting from the use of nigella sativa cream.

Design outcomes

Primary

MeasureTime frame
Pain of episiotomy. Timepoint: Immediately before the intervention,12 hours after intervention and days the first, seventh and tenth after delivery. Method of measurement: McGill Pain Questionnaire short.

Secondary

MeasureTime frame
Wound healing of episiotomy. Timepoint: Days the first, ?seventh and tenth after delivery. Method of measurement: Reeda scale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNahid Barati

Mashhad University of Medical Sciences

baratin931@mums.ac.ir+98 51 4423 3808

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026